Literature DB >> 17609489

Mechanisms of morbid hearing loss associated with tumors of the endolymphatic sac in von Hippel-Lindau disease.

John A Butman1, H Jeffrey Kim, Martin Baggenstos, Joshua M Ammerman, James Dambrosia, Athos Patsalides, Nicholas J Patronas, Edward H Oldfield, Russell R Lonser.   

Abstract

CONTEXT: Endolymphatic sac tumors (ELSTs) are associated with von Hippel-Lindau disease and cause irreversible sensorineural hearing loss (SNHL) and vestibulopathy. The underlying mechanisms of audiovestibular morbidity remain unclear and optimal timing of treatment is not known.
OBJECTIVE: To define the mechanisms underlying audiovestibular pathophysiology associated with ELSTs. DESIGN, SETTING, AND PATIENTS: Prospective and serial evaluation of patients with von Hippel-Lindau disease and ELSTs at the National Institutes of Health between May 1990 and December 2006. MAIN OUTCOME MEASURES: Clinical findings and audiologic data were correlated with serial magnetic resonance imaging and computed tomography imaging studies to determine mechanisms underlying audiovestibular dysfunction.
RESULTS: Thirty-five patients with von Hippel-Lindau disease and ELSTs in 38 ears (3 bilateral ELSTs) were identified. Tumor invasion of the otic capsule was associated with larger tumors (P = .01) and occurred in 7 ears (18%) causing SNHL (100%). No evidence of otic capsule invasion was present in the remaining 31 ears (82%). SNHL developed in 27 of these 31 ears (87%) either suddenly (14 ears; 52%) or gradually (13 ears; 48%) and 4 ears had normal hearing. Intralabyrinthine hemorrhage was found in 11 of 14 ears with sudden SNHL (79%; P < .001) but occurred in none of the 17 ears with gradual SNHL or normal hearing. Tumor size was not related to SNHL (P = .23) or vestibulopathy (P = .83).
CONCLUSIONS: ELST-associated SNHL and vestibulopathy may occur suddenly due to tumor-associated intralabyrinthine hemorrhage, or insidiously, consistent with endolymphatic hydrops. Both of these pathophysiologic mechanisms occur with small tumors that are not associated with otic capsule invasion.

Entities:  

Mesh:

Year:  2007        PMID: 17609489     DOI: 10.1001/jama.298.1.41

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  23 in total

1.  Neurologic manifestations of von Hippel-Lindau disease.

Authors:  John A Butman; W Marston Linehan; Russell R Lonser
Journal:  JAMA       Date:  2008-09-17       Impact factor: 56.272

Review 2.  Von Hippel-Lindau disease: a single gene, several hereditary tumors.

Authors:  J Crespigio; L C L Berbel; M A Dias; R F Berbel; S S Pereira; D Pignatelli; T L Mazzuco
Journal:  J Endocrinol Invest       Date:  2017-06-06       Impact factor: 4.256

3.  Clinicoradiologic characteristics of endolymphatic sac tumors.

Authors:  Hongbo Le; Huihong Zhang; Weijing Tao; Lan Lin; Jie Li; Lin Ma; Guobin Hong; Xin Lou
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-06-13       Impact factor: 2.503

4.  De novo development and progression of endolymphatic sac tumour in von hippel-lindau disease: an observational study and literature review.

Authors:  Nwaneka Eze; Alexander Huber; Bernhard Schuknecht
Journal:  J Neurol Surg B Skull Base       Date:  2013-05-28

5.  Prospective natural history study of central nervous system hemangioblastomas in von Hippel-Lindau disease.

Authors:  Russell R Lonser; John A Butman; Kristin Huntoon; Ashok R Asthagiri; Tianxia Wu; Kamran D Bakhtian; Emily Y Chew; Zhengping Zhuang; W Marston Linehan; Edward H Oldfield
Journal:  J Neurosurg       Date:  2014-02-28       Impact factor: 5.115

6.  Surgical resection of endolymphatic sac tumors in von Hippel-Lindau disease: findings, results, and indications.

Authors:  H Jeffrey Kim; Marygrace Hagan; John A Butman; Martin Baggenstos; Carmen Brewer; Christopher Zalewski; W Marston Linehan; Russell R Lonser
Journal:  Laryngoscope       Date:  2012-10-15       Impact factor: 3.325

7.  Endolymphatic sac tumors: experience of three cases.

Authors:  Pierre-Louis Bastier; Erwan de Mones; Magali Marro; Wael Elkhatib; Valérie Franco-Vidal; Dominique Liguoro; Vincent Darrouzet
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-12-05       Impact factor: 2.503

8.  Pituitary stalk hemangioblastomas in von Hippel-Lindau disease.

Authors:  Russell R Lonser; John A Butman; Ruwan Kiringoda; Debbie Song; Edward H Oldfield
Journal:  J Neurosurg       Date:  2009-02       Impact factor: 5.115

Review 9.  Von Hippel-Lindau disease.

Authors:  Prashant Chittiboina; Russell R Lonser
Journal:  Handb Clin Neurol       Date:  2015

10.  Endolymphatic Sac Tumour: A Neoplastic Cause for Meniere's Syndrome.

Authors:  S Raghunandhan; P Vijaya Krishnan; Sathiya Murali; R S Anand Kumar; Mohan Kameswaran
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.